Your browser doesn't support javascript.
loading
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.
Wang, Ying; Su, Lijing; Morin, Matthew D; Jones, Brian T; Mifune, Yuto; Shi, Hexin; Wang, Kuan-Wen; Zhan, Xiaoming; Liu, Aijie; Wang, Jianhui; Li, Xiaohong; Tang, Miao; Ludwig, Sara; Hildebrand, Sara; Zhou, Kejin; Siegwart, Daniel J; Moresco, Eva Marie Y; Zhang, Hong; Boger, Dale L; Beutler, Bruce.
Afiliación
  • Wang Y; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Su L; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Morin MD; Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.
  • Jones BT; Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.
  • Mifune Y; Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.
  • Shi H; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Wang KW; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Zhan X; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Liu A; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Wang J; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Li X; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Tang M; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Ludwig S; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Hildebrand S; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Zhou K; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Siegwart DJ; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Moresco EMY; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Zhang H; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Boger DL; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Beutler B; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Proc Natl Acad Sci U S A ; 115(37): E8698-E8706, 2018 09 11.
Article en En | MEDLINE | ID: mdl-30150374
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Adyuvantes Inmunológicos / Receptor Toll-Like 1 / Receptor Toll-Like 2 / Antígeno B7-H1 / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Adyuvantes Inmunológicos / Receptor Toll-Like 1 / Receptor Toll-Like 2 / Antígeno B7-H1 / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2018 Tipo del documento: Article